Understanding how T cells can be made more effective against cancer
TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunction
This study is looking into why some immune cells called T cells, which help fight cancer, stop working properly and can't attack tumors effectively, and it aims to find ways to improve cancer treatments like immunotherapy for people with liver and breast cancer.
Quick facts
| Grant type | R37 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11059240 on NIH RePORTER |
What this research studies
This research investigates why certain T cells, which are crucial for fighting cancer, become dysfunctional and unable to effectively eliminate tumor cells. By using mouse models and analyzing human tumor-infiltrating lymphocytes, the study aims to uncover the mechanisms behind T cell dysfunction, particularly focusing on their inability to enter the cell cycle in response to stimulation. The researchers will explore how these findings can inform strategies to enhance the effectiveness of immunotherapies, such as checkpoint inhibitors, in treating cancers like liver and breast cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with liver or breast cancer who are undergoing immunotherapy or have tumor-infiltrating lymphocytes.
Not a fit: Patients with cancers that do not involve T cell dysfunction or those who are not receiving immunotherapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved immunotherapy treatments that restore the functionality of T cells in cancer patients, potentially leading to better outcomes.
How similar studies have performed: Other research has shown promising results in understanding T cell dysfunction in cancer, indicating that this approach has potential for significant advancements.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Philip, Mary — Vanderbilt University Medical Center
- Study coordinator: Philip, Mary
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.